About Us

Mission

Provide solutions to pioneer excellence in gene editing analysis

Vision

Empower innovation with integrity and collaboration

Core Values

Stay commited to collaboration, innovation and integrity

Why Countagen and Why Now?

Gene editing has opened many opportunities to transform research, drug development and personalized medicine. The real power of gene editing is being able to choose exactly where to edit a gene. Measuring the efficiency and specificity of gene editing is a critical step to ensure success and advance to practical applications. A typical gene editing workflow requires the assessment of different conditions before moving to functional assays. Methods used routinely to achieve this are multimodal and often require long time and different resources for optimization and data analysis. At Countagen, we are committed to accelerating this process by providing complete solutions that ensure swift and reliable quantification of gene editing efficiency.

The Team Origins

Countagen is a spin-off company from Mats Nilsson’s Lab at Stockholm University & Science for Life Laboratory in Sweden. We are committed to providing solutions to pioneer excellence in gene editing analysis. Our team gathers 20+ years of cutting-edge innovation in molecular analysis tools and a successful entrepreneurship trajectory.

We stay committed to moving beyond traditional CRISPR analysis methods and exploring novel approaches beyond the PCR regime. 🔨 This shift is reflected in our approach, marking the end of an old regime and embracing a dawn of innovative possibilities. 🌅

Posing in front of the fake Berlin Wall is a metaphor of us preparing to tear down the walls of traditional CRISPR analysis methods and bringing down the PCR regime.

The Team

Felix Neumann

Felix Neumann

CEO

PhD in Biochemistry

Iván Hernández-Neuta

Iván Hernández-Neuta

CSO

PhD in Biochemistry

Leiore Ajuria

Leiore Ajuria

Product Manager

PhD in Genetics

Trixy Fang

Trixy Fang

Scientist

PhD in Biochemistry

Joost Bergman

Joost Bergman

Product Engineer

MSc in Biomedicine

Allison Whalen

Allison Whalen

Senior Field Application Specialist

Biotech Professional

Sonja Klose

Sonja Klose

Research Associate

MSc in Medical Biotechnology

Evelyn Lim

Evelyn Lim

Marketing & BD Intern

BEng in Biomedical Engineering

Board of Directors

Mårten Winge

Mårten Winge

Chairman of the Board

Serial Entrepreneur and CEO at Strike Pharma

Stina Wallmark

Stina Wallmark

Board Member

Investment Manager at Almi Invest and Board professional

Jon-Sverre Schanche

Jon-Sverre Schanche

Board Member

Board professional and Life Science Research, Technology and Product Development advisor

Mats Nilsson

Mats Nilsson

Board Member

Professor in Biochemistry at Stockholm University and Serial Entrepreneur

Scientific Advisors

Mats Nilsson

Mats Nilsson

Board Member

Professor in Biochemistry at Stockholm University and Serial Entrepreneur

Bernhard Schmierer

Bernhard Schmierer

Scientific Advisor

Head at the CRISPR Functional Genomics unit at Karolinska Institute

Sören Turan

Sören Turan

Scientific Advisor

Scientist at Bayer Pharmaceuticals

Partners & Supporters